Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC4A1APP2 is annotated as a **pseudogene** in the human genome. Pseudogenes are DNA sequences similar to known genes but typically nonfunctional due to mutations or lack of necessary regulatory elements. SLC4A1APP2 is related by sequence to the *solute carrier family 4, anion exchanger* genes, particularly SLC4A1, but it does not encode a functional protein. It has no known biological function, no association with disease phenotypes, and is not recognized as a receptor, enzyme, transporter, or therapeutic target[1][3][5]. **Summary of issues:** - SLC4A1APP2 is a pseudogene, not a protein-coding gene, and therefore does not serve as a molecular target for drugs or therapies. - No molecular function, biological pathways, disease involvement, or drug interactions are reported. - There is nothing to suggest it is relevant for patient selection, efficacy monitoring, or safety concerns. This entry should be flagged as **is_incorrect: true** given that it is not a molecule/receptor suitable as a therapeutic target and does not fit typical drug discovery criteria[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 4 member 1 adaptor protein pseudogene 2 (SLC4A1APP2).